Argos Therapeutics
A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases
2
Funding Rounds
$67.5m
Money raised
Overview
A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases
-
Website:
- Business model: B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ra*** M. St* | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Je D. Ab*** | - | - | - |
| Sa**** va* De* | - | - | - |
| Ig** Kr** | - | - | - |
| Hu**** Bi**** | - | - | - |
| Ir Mt* | - | - | - |
| Ri G. Mo* | - | - | - |
| Ro**** F. Ca*** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Argos Therapeutics has raised a total of $67.5m in funding over 2 rounds.
Key Insights:
- Argos Therapeutics Series E round: $42.5m
- Argos Therapeutics Series D round: $25m
Argos Therapeutics Series E round
$42.5m
Argos Therapeutics Series D round
$25m
Industries
Argos Therapeutics is active in the following industries: